Skip to main content
Log in

Salting-out-assisted liquid–liquid extraction as a suitable approach for determination of methoxetamine in large sets of tissue samples

  • Research Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

A new designer drug, a dissociative anesthetic, and a putative N-methyl-d-aspartate receptor antagonist, methoxetamine (MXE) noted by the EU Early Warning System has been already identified as a cause of several fatalities worldwide. The primary objective of this work was to develop a suitable sample preparation method allowing for isolation of MXE and its main metabolites in high yields from rat brain, liver, and lungs. For the purpose of the project, MXE and five metabolites were synthesized in-house, specifically O-desmethyl-normethoxetamine, O-desmethylmethoxetamine, dihydro-O-desmethylmethoxetamine, normethoxetamine, and dihydromethoxetamine. A sample preparation procedure consisted in the homogenization of the tissue applying salting-out-assisted liquid–liquid extraction (SALLE). A subsequent liquid chromatography-mass spectrometry (LC-MS) analysis was based on reversed-phased chromatography hyphenated with a triple quad MS system in a positive electrospray mode. Multiple reaction monitoring (MRM) was used for qualification and quantification of the analytes. The quantification was based on the application of an isotopically labeled internal standard, normethoxetamine-d3. The matrix-matched calibrations were prepared for each type of matrix with regression coefficients 0.9943–1.0000. The calibration curves were linear in the concentration range of 2.5–250 ng g−1. Limits of quantification (LOQs) were estimated as 2.5 and 5 ng g−1, respectively. Recovery (80–117 %) and matrix effect (94–110 %) at 100 ng g−1 and intra- and inter-day accuracy and precision at low (2.5 ng g−1), middle (25 ng g−1), and upper (250 ng g−1) concentration levels for all the analytes in all three types of tissues were also determined. The developed analytical method was applied to a set of real samples gathered in toxicological trials on rats and MXE, and its metabolites were determined successfully.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. EMCDDA (2014) Methoxetamine—report on the risk assessment of 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) in the framework of the Council Decision on new psychoactive substances, Lisbon

  2. Kjellgren A, Jonsson K (2013) Methoxetamine (MXE)—a phenomenological study of experiences induced by a “legal high” from the internet. J Psychoactive Drugs 45:276–286

    Article  Google Scholar 

  3. Meyer MR, Bach M, Welter J, Bovens M, Turcant A, Maurer HH (2013) Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSn. Anal Bioanal Chem 405:6307–6321

    Article  CAS  Google Scholar 

  4. Corazza O, Assi S, Schifano F (2013) From “Special K” to “Special M”: the evolution of the recreational use of ketamine and methoxetamine. CNS Neurosci Ther 19:454–460

    Article  CAS  Google Scholar 

  5. Shields JE, Dargan PI, Wood DM, Puchnarewicz M, Davies S, Waring WS (2012) Methoxetamine associated reversible cerebellar toxicity: three cases with analytical confirmation. Clin Toxicol 50:438–440

    Article  CAS  Google Scholar 

  6. Wiergowski M, Anand JS, Krzyżanowski MJZ (2014) Acute methoxetamine and amphetamine poisoning with fatal outcome: a case report. Int J Occup Med Environ Health 27:683–690

    Article  Google Scholar 

  7. Hays PA, Casale JF, Berrier AL (2012) The characterization of 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (Methoxetamine). Microchem J 9:3–17

    CAS  Google Scholar 

  8. Hydzik P, Gomółka E, Sulka A, Cudzich-czop S (2012) Acute methoxetamine poisoning—case report. 91:235–242

  9. Loeffler G, Craig C (2013) Methoxetamine misuse and toxicity. J Stud Alcohol Drugs 74:816–817

    Article  Google Scholar 

  10. De Paoli G, Brandt SD, Wallach J, Archer RP, Pounder DJ (2013) From the street to the laboratory: analytical profiles of methoxetamine, 3-methoxyeticyclidine and 3-methoxyphencyclidine and their determination in three biological matrices. J Anal Toxicol 37:277–283

    Article  Google Scholar 

  11. Abe E, Ricard F, Darrouzain F, Alvarez JC (2013) An automated method for measurement of methoxetamine in human plasma by use of turbulent flow on-line extraction coupled with liquid chromatography and mass spectrometric detection. Anal Bioanal Chem 405:239–245

    Article  CAS  Google Scholar 

  12. Zawilska JB (2014) Methoxetamine—a novel recreational drug with potent hallucinogenic properties. Toxicol Lett 230:402–407

    Article  CAS  Google Scholar 

  13. Al-Saffar Y, Stephanson NN, Beck O (2013) Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine—experience from the Swedish population. J Chromatogr B Anal Technol Biomed Life Sci 930:112–120

    Article  CAS  Google Scholar 

  14. Menzies EL, Hudson SC, Dargan PI, Parkin MC, Wood DM, Kicman AT (2014) Characterizing metabolites and potential metabolic pathways for the novel psychoactive substance methoxetamine. Drug Test Anal 6:506–515

    Article  CAS  Google Scholar 

  15. Zhang J, Wu H, Kim E, El-Shourbagy TA (2009) Salting-out assisted liquid/liquid extraction with acetonitrile: a new high throughput sample preparation technique for good laboratory practice bioanalysis using liquid chromatography-mass spectrometry. Biomed Chromatogr 23:419–425

    Article  CAS  Google Scholar 

  16. Liu J, Jiang M, Li G, Xu L, Xie M (2010) Miniaturized salting-out liquid-liquid extraction of sulfonamides from different matrices. Anal Chim Acta 679:74–80

    Article  CAS  Google Scholar 

  17. Wu H, Zhang J, Norem K, El-Shourbagy TA (2008) Simultaneous determination of a hydrophobic drug candidate and its metabolite in human plasma with salting-out assisted liquid/liquid extraction using a mass spectrometry friendly salt. J Pharm Biomed Anal 48:1243–1248

    Article  CAS  Google Scholar 

  18. Valente IM, Gonçalves LM, Rodrigues JA (2013) Another glimpse over the salting-out assisted liquid-liquid extraction in acetonitrile/water mixtures. J Chromatogr A 1308:58–62

    Article  CAS  Google Scholar 

  19. Anastassiades M, Scherbaum E (2005) Chapter 4 sample handling and clean-up procedures II-new developments. Compr Anal Chem 43:113–233

    Article  CAS  Google Scholar 

  20. Schenck FJ, Callery P, Gannett PM, Daft JR, Lehotay SJ (2002) Schenck.pdf. J AOAC Int 85:1177–1180

    CAS  Google Scholar 

  21. Guo Y-C, Li X-H, Zhao L-J, Zhang Y-H (2013) Drawing out the structural information about the first hydration layer of the isolated Cl− anion through the FTIR-ATR difference spectra. J Solut Chem 42:459–469

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This study was funded by a specific university research grant (project MSMT No 20/2015) and by the Ministry of Interior of the Czech Republic (project VG20122015075, New synthetic drugs (NSD)—creation of toxicological database, development and validation of detection methods including fast immunochemical tests, behavioral pharmacology, pharmacokinetics and biotransformation in rats, epidemiology).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Sykora.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(PDF 635 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hajkova, K., Jurasek, B., Sykora, D. et al. Salting-out-assisted liquid–liquid extraction as a suitable approach for determination of methoxetamine in large sets of tissue samples. Anal Bioanal Chem 408, 1171–1181 (2016). https://doi.org/10.1007/s00216-015-9221-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-015-9221-1

Keywords

Navigation